![TG Therapeutics](https://gocience.com/logos/new/c73fe32a584ed89e9f3abb750f49333b8d6fc252197494d9a4bb58fd4707a300.png)
Tg Therapeutics
Biotechnology, 2 Gansevoort St Fl 9, New York, 10014, United States, 201-500 Employees
Phone Number: +18*********
Who is TG THERAPEUTICS
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline in...
Read More
![map](/x-assets/maps1.0-950f22e3512fa69a51fdf6612dcb593a74c2f8790b6e4ec5601cebb82b592ab9.png)
-
Headquarters: 2 Gansevoort St Fl 9, New York, New York, 10014, United States
-
Date Founded: 2011
-
Employees: 201-500
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 511210 |
Show More
Does something look wrong? Fix it. | View contact records from TG THERAPEUTICS
TG Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding TG Therapeutics
Answer: TG Therapeutics's headquarters are located at 2 Gansevoort St Fl 9, New York, 10014, United States
Answer: TG Therapeutics's phone number is +18*********
Answer: TG Therapeutics's official website is https://tgtherapeutics.com
Answer: TG Therapeutics's revenue is $1 Million to $5 Million
Answer: TG Therapeutics's SIC: 2834
Answer: TG Therapeutics's NAICS: 511210
Answer: TG Therapeutics has 201-500 employees
Answer: TG Therapeutics is in Biotechnology
Answer: TG Therapeutics contact info: Phone number: +18********* Website: https://tgtherapeutics.com
Answer: TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month